Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  conjugated estrogens
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-16 of 16 for your search:
Start Over
Phase II/III Chemotherapy with CTX/ADR/5-FU/MTX with and without Cell Synchronization with Tamoxifen and Premarin for Metastatic Breast Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: NCI-76-C-377A, NCI-MB-160A
Phase II/III Chemotherapy with CTX/ADR/MTX/5-FU, with vs without Hormonal Synchronization with TMX/Premarin, for Metastatic Mammary Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-76-C-377B, NCI-MB-160B
Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069015, E-2193, NCI-P01-0194, ECOG-E2193, NCT00026286
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069502, NCCTG-N01C8, NCI-P02-0229, N01C8, NCT00043069
Phase III Sequential MTX/5-FU with Continuous TMX vs Sequential MTX/5-FU with Hormonal Synchronization (TMX and Premarin) for Metastatic Breast Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-BRE-83309
Phase III Therapy with CAMFTP (CTX/ADR/MTX/5-FU/TMX/Premarin) for Inflammatory Stage IV or Stage III Breast Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-76-C-377C, NCI-MB-160C, NCI-T83-1293N, T83-1293
Phase III Multimodality Approach to Patients with Inflammatory and Locally Advanced Noninflammatory Stage III Carcinoma of the Breast and Metastatic (Stage IV) Breast Carcinoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-84-C-216, BRMP-8607, NCI-86-C-188, NCI-MB-198, NCI-T84-0518N, T84-0518
Phase II Intensive Induction with CTX/ADR/MTX/5-FU/VCR/CF/Premarin plus Maintenance with the Induction Agents plus DAVA/MITO for Metastatic Breast Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-83-C-149, NCI-MB-184, NCI-T83-1137N, T83-1137
Phase II Salvage Chemotherapy with Intermediate-Dose MTX Followed by 5-FU in Patients with Metastatic Breast Cancer Who Have Failed Prior Chemotherapy
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-84-C-85, NCI-MB-193, NCI-T84-0345N, T84-0345
CAF (CTX/ADR/5-FU) with or without Hormone Synchronization with MEG and Premarin for Advanced Endometrial Adenocarcinoma
Phase: No phase specified
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: NCI-79-C-72, NCI-MB-125
Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: Postmenopausal
Sponsor: Other
Protocol IDs: CDR0000355122, CRUK-HRT, EU-20112, ISRCTN29941643, NCT00079248
Start Over